Showcases Stock ranks Forex

Karyopharm Therapeutics Inc. (KPTI)
16.32  0.23 (1.43%) 09-18 16:00
Open: 16.42 Pre. Close: 16.09
High: 16.48 Low: 15.87
Volume: 1,504,051 Market Cap: 1,199M
Karyopharm Therapeutics, Inc. is an oncology-focused pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. The company is headquartered in Newton Center, Massachusetts and currently employs 332 full-time employees. The firm is focused on the discovery, development, and commercialization of drugs directed against nuclear export and related targets for the treatment of cancer and other diseases. Its selective inhibitor of nuclear export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1). Its lead compound, XPOVIOTM (selinexor), received accelerated approval from the Food and Drug Administration (FDA), in combination with dexamethasone as a treatment for patients with heavily pretreated multiple myeloma. Its XPOVIO is an oral SINE compound, which blocks the nuclear export of tumor suppressor, growth regulatory and anti-inflammatory proteins, leading to accumulation of these proteins in the nucleus and enhancing their anti-cancer activity in the cell. The company is also focused on developing treatments for other diseases, such as Hematologic Malignancies and Solid Tumor Malignancies.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 16.49 - 16.539 16.539 - 16.593
Low: 15.724 - 15.782 15.782 - 15.848
Close: 16.214 - 16.305 16.305 - 16.406
Stock Technical Analysis
Target: Six months: 19.25
One year: 22.48
Support: Support1: 14.82
Support2: 13.80
Resistance: Resistance1: 16.48
Resistance2: 19.25
Pivot: 15.33
Moving Averages: MA(5): 15.91
MA(20): 15.07
MA(100): 17.53
MA(250): 17.12
MACD: MACD(12,26): 0.03
Signal(12,26,9): -0.22
%K %D: %K(14,3): 91.43
%D(3): 90.10
RSI: RSI(14): 58.20
52-Week: High: 29.61
Low: 8.915
Change(%): 62.2
Average Vol(K): 3-Month: 151573
10-Days: 125843
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.

KPTI has closed below upper band by 5.9%. Bollinger Bands are 39.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Wed, 16 Sep 2020
The Rejuvenation of Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - The Oracle Dispatch

Tue, 15 Sep 2020
Karyopharm Therapeutics Inc. [KPTI] is -20.29% lower this YTD. Is it still time to buy? - The DBT News

Mon, 14 Sep 2020
How Should Investors React To Karyopharm Therapeutics' (NASDAQ:KPTI) CEO Pay? - Yahoo Finance

Fri, 11 Sep 2020
Implied Volatility Surging for Karyopharm Therapeutics (KPTI) Stock Options - Yahoo Finance

Thu, 10 Sep 2020
Christopher Brett Primiano Sells 10,054 Shares of Karyopharm Therapeutics Inc (NASDAQ:KPTI) Stock - MarketBeat

Tue, 01 Sep 2020
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - WFMZ Allentown

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 73.48
Shares Float (M) 48.64
% Held by Insiders 12.78
% Held by Institutions 91.03
Shares Short (K) 14280
Shares Short Prior Month (K) 15570
Stock Financials
EPS -2.840
Book Value (p.s.) 1.770
Profit Margin -228.44
Operating Margin -205.49
Return on Assets (ttm) -34.5
Return on Equity (ttm) -178.4
Qtrly Rev. Growth 253.0
Gross Profit (p.s.) -1.141
Sales Per Share 1.128
EBITDA (p.s.) -2.305
Qtrly Earnings Growth
Operating Cash Flow (M) -161.28
Levered Free Cash Flow (M) -90.79
Stock Valuation
PE Ratio -5.75
PEG Ratio
Price to Book value 9.22
Price to Sales 14.47
Price to Cash Flow -7.44
Stock Dividends
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator